A fierce debate is underway about where to draw the line between normal and abnormal when it comes to the condition called “gestational diabetes”. Medical groups have recently made changes that dramatically expand the number of women classified as having this condition – but some fear a fresh case of over-medicalisation which will see many healthy women unncessarily labelled as sick. Read more in Ray’s latest column, available free here in the Medical Journal of Australia
The problem of “overdiagnosis” is increasingly being seen as a significant threat to human health. In Ray’s latest article published in the British Medical Journal, he and co-authors lay out the nature of the problem, describe some examples, explore causes and flag possible solutions. You can read the full text here
An international conference called Preventing Overdiagnosis will take place on September 10-12, 2013, at Dartmouth College in the United States. To go to the conference website, click here
Ray’s latest column in the British Medical Journal celebrates a fantastic song by one of Australia’s great bands, and the potential healing power of music. Here you can read the full text of Times like these you need some One Four Five
In a column in the latest Medical Journal of Australia Ray explores the challenges of “disinvesting” in useless or dangerous health care. A healthy dose of disinvestment can be read here
In Ray’s latest monthly column for the Medical Journal of Australia he argues its time for full disclosure of all financial relationships between our health professionals and drug and device makers. Evert speaking fee, every trip away and every free lunch.
Rather than tinkering with codes of ethics, a new law like the United State’s Sunshine Act is whats needed. Here you can read the full text of the column
At ABC Radio National’s Background Briefing program, listen to Petra Helesic describe how she marketed medicines to Australian doctors for more than a decade, and the debate over the need for more transparency about the secret payments that regularly flow from companies to leading specialists